FDA Approved Alzheimer's Drug Despite Some Staff Concerns 

Some at the Food and Drug Administration said there wasn't enough evidence to approve the drug from Biogen, and the agency's decision to approve the drug has sparked criticism.

Philip Morris International to Move Headquarters to Connecticut 

The tobacco company plans to move 200 jobs to a not-yet-named location in the southwestern part of the state from New York City.

Amazon's Planned Purchase of MGM Faces FTC Scrutiny 

The antitrust review of the acquisition comes as Lina Khan, a frequent critic of the online giant, takes the helm at the commission.

McDonald's Loyalty Program Goes National 

Customers will receive points on qualifying purchases that can be traded for items under the program, which is set to launch nationally on July 8.

LinkedIn Accounts of Scholars Blocked in China 

Affected users say the social-networking site owned by Microsoft is obstructing them over "prohibited content" without further explanation.

Google Faces EU Antitrust Probe of Alleged Ad-Tech Abuses 

The European Union opened a formal antitrust investigation into allegations that Google abuses its leading role in the advertising-technology sector, the most wide-ranging case yet to look at that pillar of the tech giant's business.

Blackstone Bets $6 Billion on Buying and Renting Homes 

The investment firm's deal for a company that buys and rents single-family homes is the latest sign Wall Street believes the U.S. housing market is going to stay hot.

Vivendi Shareholders Approve Spinoff of Universal Music 

The vote brings the world's largest music company a step closer to becoming its own public entity.

Pear Therapeutics to Go Public in Roughly $1.6 Billion SPAC Deal 

Investors that include the Pritzker Vlock Family Office and Neuberger Berman Group funds are backing a roughly $125 million private investment in public equity, or PIPE, as part of the proposed deal.

Amazon Could Use Less Prime Time 

Prime Day showcases all the strengths that have put Amazon under intense scrutiny.


(END) Dow Jones Newswires

June 22, 2021 17:15 ET (21:15 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.